Squarepoint Ops LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 12,062 shares of the company's stock, valued at approximately $280,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its position in shares of Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after purchasing an additional 8,400,208 shares during the last quarter. Norges Bank bought a new stake in shares of Option Care Health in the 4th quarter worth about $60,219,000. Freestone Grove Partners LP bought a new stake in shares of Option Care Health in the 4th quarter worth about $17,487,000. Dimensional Fund Advisors LP increased its position in shares of Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Finally, Victory Capital Management Inc. increased its position in shares of Option Care Health by 31.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after purchasing an additional 503,840 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on OPCH shares. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and an average price target of $35.50.
Read Our Latest Stock Analysis on Option Care Health
Option Care Health Stock Performance
Option Care Health stock traded up $0.48 during mid-day trading on Tuesday, reaching $32.15. The company had a trading volume of 1,119,929 shares, compared to its average volume of 1,870,830. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a 50 day moving average of $32.30 and a 200-day moving average of $30.14. The firm has a market cap of $5.26 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 2.30 and a beta of 0.74.
Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter in the prior year, the company posted $0.26 EPS. The business's revenue was up 16.3% on a year-over-year basis. On average, sell-side analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.